Transforming growth factor-β1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1590, Issue 1-3, 2002, Pages 1-15

  Rosado, Enrique ^a,b   Schwartz, Zvi ^a,c   Sylvia, Victor L ^a   Dean, David D ^a   Boyan, Barbara D ^a,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

1,25 (OH)2D3; Alkaline phosphatase; Chondrocyte culture; Protein kinase C; Signal transduction; Transforming growth factor 1

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; ALKALINE PHOSPHATASE; ARACHIDONIC ACID; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; DIOCTANOIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INDOMETACIN; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROSTAGLANDIN E2; PROSTANOID; PROTEIN KINASE C; RECEPTOR ANTIBODY; STAUROSPORINE; SULFATE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE III; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH PLATE; GROWTH REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; ARACHIDONIC ACID; CELLS, CULTURED; CHONDROCYTES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; GROWTH PLATE; MODELS, BIOLOGICAL; PHOSPHOLIPASES A; PROTEIN KINASE C; PROTEOGLYCANS; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

CANIS FAMILIARIS;

EID: 0037067182     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00194-5     Document Type: Article

References (78)

1. Differentiation of rat mesenchymal cells by cartilage-inducing factor: Enhanced phenotypic expression by dihydrocytochalasin B
2. Transforming growth factor-beta modulates the expression of osteoblasts and chondroblast phenotypes in vitro
3. Cartilage inducing factor-A: Apparent identity to transforming growth factor-beta
4. Transforming growth factor beta: An autocrine regulator of chondrocytes
5. Transforming growth factor-beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures
6. Direct effects of transforming growth factor-β on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner
7. Temporal and spatial expressions of transforming growth factor-betas and their receptors in epiphyseal growth plate
8. 3 1α- and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner
9. 3 on differentiation of a human osteosarcoma (MG-63)
10. 3 and transforming growth factor beta (TGF beta)
11. Regulation of c-fos gene induction and mitogenic effect of transforming growth factor-β1 in rat articular chondrocyte
12. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis
13. Production and action of transforming growth factor-beta in human osteoblast cultures: Dependence on cell differentiation and modulation by calcitriol
14. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
15. Immunoreactive localization of transforming growth factor-beta type II receptor-positive cells in rat tibiae
16. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis
17. Molecular mechanisms of transforming growth factor-β signaling
18. Smads are the central component in transforming growth factor-β signaling
19. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
20. Regulation of protein kinase C by transforming growth factor-beta-1 in rat costochondral chondrocyte cultures
21. Inhibitory effect of H-7, H-8 and polymyxin G on liver protein kinase C-induced phosphorylation of endogenous substrates
22. The synergistic effects of vitamin D metabolites and TGFβ on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways
23. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: Attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin
24. SBF cell cycle regulator as a target of the yeast PKC-MAP kinase pathway
25. Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells
26. The protein kinase C isoforms leading to MAP-kinase activation in CHO cells
27. Activation of specific MEK-ERK cascade is necessary for TGFβ signaling and crosstalk with PKA and PKC pathways in cultured rat articular chondrocytes
28. Transforming growth factor-β1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism
29. Transforming growth factor-β1 regulation of resting zone chondrocytes is mediated by two separate but interacting pathways
30. 3 on growth plate chondrocytes
31. 3-mediated effects on resting zone chondrocytes
32. 3
33. Measurement of protein using bicinchoninic acid
34. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro
35. 3
36. 3 involves cell maturation specific membrane receptor activated phospholipid metabolism
37. Dexamethasone promotes von Kossa-positive nodule formation and increased alkaline phosphatase activity in costochondral chondrocyte cultures
38. The membrane effects of 17β-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins
39. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro
40. Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes
41. Sex-dependent effects of 17-β-estradiol on chondrocyte differentiation in culture
42. Sex steroid enhancement of matrix production by chondrocytes is sex and cell maturation specific
43. Alkaline phosphatases
44. 2 specific activities
45. Chelerythrine is a potent and specific inhibitor of protein kinase C
46. Multiple effects of staurosporine, a kinase inhibitor, on thymocyte functions: Comparison with the effect of tyrosine kinase inhibitors
47. 2 and phospholipase C in growth zone chondrocytes
48. 3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner
49. 2 on costochondral chondrocyte differentiation is mediated by cAMP and protein kinase C
50. 2 production by vitamin D metabolites in growth zone and resting zone chondrocyte cultures is dependent on cell maturation
51. 3 effects on growth zone chondrocytes
52. Molecular mechanisms of diverse actions of prostanoid receptors
53. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C
54. 3
55. Mixed micelle assay of protein kinase C
56. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
57. Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets
58. 3 is dependent on cell maturation state (resting zone cells) and is specific to the PLD2 isoform
59. R 59 022, a diacylglycerol kinase inhibitor: Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet
60. Early cell cycle diacylglycerol (DAG) content and protein kinase C (PKC) activity enhancement potentiates prostaglandin F2 α (PGF2 α) induced mitogenesis in Swiss 3T3 cells
61. A diacylglycerol kinase inhibitor, R 59 022, potentiates superoxide anion production and 46-kDa protein phosphorylation in guinea pig polymorphonuclear leukocytes
62. Effect of Wortmannin and 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) on N-formyl-methionyl-leucyl-phenylalanine-induced phospholipase D activation in differentiated HL60 cells: Possible involvement of phosphatidylinositol 3-kinase in phospholipase D activation
63. Protein Kinase C: Structure, function and regulation
64. 3
65. Characterization of plasma membrane proteins in mammalian kidney: I. Preparation of a membrane fraction and separation of the protein
66. Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage
67. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification
68. Blockade of the spinal excitatory effect of cAMP on the startle reflex by intrathecal administration of the isoquinoline sulfonamide H-8: Comparison to the protein kinase C inhibitor H-7
69. The structure and biological activities of the widely used protein kinase inhibitor, H7, differ depending on the commercial source
70. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C
71. 2+/calmodulin-dependent protein kinase II
72. Mimicry and inhibition of nerve growth factor effects: Interactions of staurosporine, forskolin, and K252a in PC 12 cells and normal rat chromaffin cells in vitro
73. Lipid mediators and protein kinase C activation for the intracellular signaling network
74. Transforming growth factor-β-mediated proliferation of renal tubular epithelial cells involves pertussis toxin-sensitive G-protein- and protein kinase C-dependent pathways
75. G proteins: Transducers of receptor-generated signals
76. Direct effect of arachidonic acid on protein kinase C and LH-stimulated steroidogenesis in rat Leydig cells; Evidence for tonic inhibitory control of steroidogenesis by protein kinase C
77. 3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes
78. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR)